atomoxetine hydrochloride has been researched along with viloxazine in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 2 (50.00) | 2.80 |
Authors | Studies |
---|---|
Li, B; Li, X; Li, Y; Wang, P; Xue, W; Yang, F; Yao, X; Zheng, G; Zhu, F | 1 |
Horder, J; Matthews, PRL; Pearce, M | 1 |
Bellato, A; Cortese, S; Faraone, SV; Khoury, NM; Radonjić, NV | 1 |
Price, MZ; Price, RL | 1 |
2 review(s) available for atomoxetine hydrochloride and viloxazine
Article | Year |
---|---|
Selective noradrenaline reuptake inhibitors for schizophrenia.
Topics: Adrenergic Uptake Inhibitors; Adult; Atomoxetine Hydrochloride; Citalopram; Cognition; Humans; Morpholines; Quality of Life; Randomized Controlled Trials as Topic; Reboxetine; Schizophrenia; Serotonin and Noradrenaline Reuptake Inhibitors; Viloxazine | 2018 |
Nonstimulant Medications for Attention-Deficit/Hyperactivity Disorder (ADHD) in Adults: Systematic Review and Meta-analysis.
Topics: Adult; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Guanfacine; Humans; Randomized Controlled Trials as Topic; Viloxazine | 2023 |
2 other study(ies) available for atomoxetine hydrochloride and viloxazine
Article | Year |
---|---|
Exploring the Inhibitory Mechanism of Approved Selective Norepinephrine Reuptake Inhibitors and Reboxetine Enantiomers by Molecular Dynamics Study.
Topics: Amino Acid Motifs; Antipsychotic Agents; Atomoxetine Hydrochloride; Binding Sites; Humans; Maprotiline; Molecular Docking Simulation; Molecular Dynamics Simulation; Morpholines; Neurotransmitter Uptake Inhibitors; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Protein Binding; Protein Conformation, alpha-Helical; Protein Conformation, beta-Strand; Protein Interaction Domains and Motifs; Reboxetine; Stereoisomerism; Structural Homology, Protein; Thermodynamics; Viloxazine | 2016 |
Extended-Release Viloxazine Compared with Atomoxetine for Attention Deficit Hyperactivity Disorder.
Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic Uptake Inhibitors; Adult; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Double-Blind Method; Humans; Propylamines; Retrospective Studies; Sleep Initiation and Maintenance Disorders; Treatment Outcome; Viloxazine | 2023 |